Everlight Chemical Industrial Corporation AI Stock Analysis
Everlight Chemical Industrial Corporation (1711) AI Stock Analysis
Everlight Chemical Industrial Corporation
(TWSE:1711)
Everlight Chemical scores poorly, driven primarily by deteriorating fundamentals: multi-year revenue declines, steadily compressing gross margins, and a swing to both operating and net losses, compounded by negative free cash flow as capital spending absorbed all operating cash. The conservative balance sheet — low leverage and equity covering nearly two-thirds of assets — is the main offsetting strength and limits financial risk. Technicals reinforce the caution, with the price below all key moving averages and negative MACD momentum, though oversold RSI and stochastic readings suggest selling may be extended. Valuation offers little support, as the extremely elevated P/E reflects depressed earnings and the sub-1% dividend yield provides limited compensation.
Everlight Chemical Industrial Corporation (1711) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 21.89B
- Dividend Yield
- 0.80%
- Average Volume (3M)
- 8.63M
- Price to Earnings (P/E)
- 266.8
- Beta (1Y)
- 1.11
- Revenue Growth
- -2.22%
- EPS Growth
- 33.13%
- Country
- TW
- Employees
- 1,675
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Everlight Chemical Industrial Corporation Business Overview & Revenue Model
Company Description
Everlight Chemical Industrial Corporation, founded in Taipei, Taiwan, in 1972, operates as a global producer and distributor of a diverse array of chemical products. Its extensive market reach spans Taiwan, the broader Asian region, the United States...
Everlight Chemical Industrial Corporation Financial Statement Overview
Summary
Financial results are weak overall. Revenue has declined in four of the last five years, falling 2.5% to NT$7.57 billion, while gross margin compressed to 19.0% and the company swung to an operating loss of NT$196 million and a net loss of NT$136 million (Income Statement score 31). The balance sheet is the clear strength, with equity funding 64% of assets and a conservative 0.37 debt-to-equity ratio, though return on equity has turned negative at -1.7% (Balance Sheet score 67). Cash flow is mixed: operating cash flow of NT$735 million remains solidly positive and well above the net loss, but heavy capital spending pushed free cash flow to negative NT$40 million, the weakest in five years (Cash Flow score 46).
Income Statement
31NegativeBalance Sheet
67PositiveCash Flow
46Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.82B | 7.57B | 8.17B | 7.86B | 8.89B | 9.20B |
| Gross Profit | 1.54B | 1.44B | 1.79B | 1.60B | 2.00B | 2.21B |
| EBITDA | 639.18M | 462.98M | 1.04B | 853.90M | 1.23B | 1.35B |
| Net Income | 72.69M | -136.16M | 243.59M | 85.87M | 374.43M | 472.97M |
Balance Sheet | ||||||
| Total Assets | 14.03B | 12.79B | 13.24B | 12.90B | 13.13B | 14.14B |
| Cash, Cash Equivalents and Short-Term Investments | 1.42B | 1.22B | 1.41B | 1.51B | 1.28B | 1.54B |
| Total Debt | 3.18B | 2.99B | 2.93B | 3.05B | 3.03B | 3.57B |
| Total Liabilities | 4.85B | 4.36B | 4.43B | 4.24B | 4.33B | 5.03B |
| Stockholders Equity | 8.91B | 8.18B | 8.54B | 8.34B | 8.46B | 8.81B |
Cash Flow | ||||||
| Free Cash Flow | 52.75M | -40.15M | 267.04M | 827.97M | 420.96M | 496.60M |
| Operating Cash Flow | 832.91M | 735.46M | 979.53M | 1.28B | 853.17M | 757.24M |
| Investing Cash Flow | -742.69M | -854.89M | -696.25M | -783.10M | -375.26M | -272.98M |
| Financing Cash Flow | -91.42M | -131.00M | -393.68M | -368.80M | -683.90M | -351.61M |
Everlight Chemical Industrial Corporation Peers Comparison
Overall Rating
TW:172363Neutral
TW:171460Neutral
TW:170957Neutral
TW:171144Neutral
TW:131340Underperform
TW:131230Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 63Neutral | TWD 16.23B | 19.91 | ― | 2.65% | 7.82% | 10.83% | |
| 60Neutral | TWD 15.46B | 13.39 | ― | 1.14% | 36.28% | 243.10% | |
| 57Neutral | TWD 21.75B | 22.80 | ― | 2.19% | -3.01% | 82.22% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 44Neutral | TWD 21.66B | 266.83 | ― | 0.80% | -2.22% | 33.13% | |
| 40Underperform | TWD 15.17B | 78.33 | ― | 0.85% | -0.93% | ― | |
| 30Underperform | TWD 19.04B | -3.07 | ― | ― | 28.15% | -81.09% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:1711 | Everlight Chemical Industrial Corporation | 36.85 | 17.91 | 94.59% | |
| TW:1312 | Grand Pacific Petrochemical Corp. | 12.65 | 1.65 | 15.00% | |
| TW:1313 | UPC Technology Corporation | 11.75 | 1.34 | 12.88% | |
| TW:1709 | Formosan Union Chemical Corp. | 45.60 | 29.24 | 178.80% | |
| TW:1714 | Ho Tung Chemical Corp. | 15.80 | 7.45 | 89.24% | |
| TW:1723 | China Steel Chemical Corporation | 69.90 | -8.21 | -10.51% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
